New drug trial offers hope for Tough-to-Treat blood cancers
NCT ID NCT07139873
Summary
This study is testing whether an experimental drug called DZD8586 works better than standard treatments at controlling cancer growth in adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that has returned or stopped responding to prior therapy. About 250 participants will be randomly assigned to receive either DZD8586 or a treatment chosen by their doctor. The main goal is to see which option keeps the cancer from progressing longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
RECRUITINGNanjing, Jiangsu, China
-
National Clinical Research Center for Blood Diseases, Blood Disease Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College
NOT_YET_RECRUITINGTianjin, Tianjin Municipality, China
Conditions
Explore the condition pages connected to this study.